相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression
Antonio G. Solimando et al.
HAEMATOLOGICA (2021)
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Saemundur Rognvaldsson et al.
BLOOD CANCER JOURNAL (2021)
MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis
Mohammad H. Pourhanifeh et al.
IUBMB LIFE (2020)
Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
Jia Li et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
Giuseppe Di Lernia et al.
JOURNAL OF CLINICAL MEDICINE (2020)
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
Vanessa Desantis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
MicroRNA-20a regulates cell proliferation, apoptosis and autophagy by targeting thrombospondin 2 in cervical cancer
Qinghong Zhou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Effects of miR-181a on the biological function of multiple myeloma
Ni Liu et al.
ONCOLOGY REPORTS (2019)
MiRNAs with prognostic significance in multiple myeloma A systemic review and meta-analysis
Peipei Xu et al.
MEDICINE (2019)
Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection
Maurizia Mello-Grand et al.
CARCINOGENESIS (2019)
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes
Maria Antonia Frassanito et al.
JOURNAL OF PATHOLOGY (2019)
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
Mathilde Mathieu et al.
NATURE CELL BIOLOGY (2019)
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients
Patrizia Leone et al.
ONCOIMMUNOLOGY (2019)
Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma
Zhi-yao Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery
Silvia Catuogno et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Laboratory Features of Newly Diagnosed Multiple Myeloma Patients
Azhar Hussain et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2019)
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial
Angelo Vacca et al.
CLINICAL IMMUNOLOGY (2018)
The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma (Review)
Bingying Zhu et al.
ONCOLOGY LETTERS (2018)
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
Aurelia Lamanuzzi et al.
Oncotarget (2018)
The potential role of miRNAs in multiple myeloma therapy
Daniele Caracciolo et al.
EXPERT REVIEW OF HEMATOLOGY (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways
Shuai Zhang et al.
ONCOTARGETS AND THERAPY (2018)
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
Jahangir Abdi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Response commentary: exosomes vs microvesicles in hematological malignancies
T. L. Whiteside et al.
LEUKEMIA (2017)
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma
Shotaro Tatekawa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Prognostic role of circulating exosomal miRNAs in multiple myeloma
Salomon Manier et al.
BLOOD (2017)
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Annamaria Gulla et al.
CLINICAL CANCER RESEARCH (2016)
Expression and significance of miR-21 in multiple myeloma patients
J. H. Wang et al.
GENETICS AND MOLECULAR RESEARCH (2016)
Exosomes and nanotubes: Control of immune cell communication
Kessler McCoy-Simandle et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Targeting vasculogenesis to prevent progression in multiple myeloma
M. Moschetta et al.
LEUKEMIA (2016)
MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma
Yanjie Li et al.
LEUKEMIA RESEARCH (2016)
Targeting B-cell non Hodgkin lymphoma: New and old tricks
Antonio Giovanni Solimandoa et al.
LEUKEMIA RESEARCH (2016)
Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis
Mu Hao et al.
ONCOTARGET (2016)
Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma
Jinheng Wang et al.
ONCOTARGET (2016)
Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
Li Zhang et al.
ONCOTARGET (2016)
MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment
Lavinia Raimondi et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression
Y. B. Wei et al.
TRANSLATIONAL PSYCHIATRY (2016)
Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
Jian-Jun Zhao et al.
CANCER RESEARCH (2015)
miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma
Yijun Yang et al.
CLINICAL CANCER RESEARCH (2015)
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG 50120)
Rashid Khan et al.
HAEMATOLOGICA (2015)
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression
Weixin Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment
F. J. Kohlhapp et al.
ONCOGENE (2015)
The role of circulating miRNAs in multiple myeloma
Zhang Ji et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma
Alfons Navarro et al.
ONCOTARGET (2015)
MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma
Fei Li et al.
ONCOTARGET (2015)
miRNAs in multiple myeloma - a survival relevant complex regulator of gene expression
Anja Seckinger et al.
ONCOTARGET (2015)
Role of Extracellular Vesicles in Hematological Malignancies
Stefania Raimondo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma
Wen-Chi Yang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG 50120)
Rashid Khan et al.
HAEMATOLOGICA (2015)
The complexity of miRNA-mediated repression
A. Wilczynska et al.
CELL DEATH AND DIFFERENTIATION (2015)
Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma
Mu Hao et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MiR-29b replacement inhibits proteasomes and disrupts aggresome plus autophagosome formation to enhance the antimyeloma benefit of bortezomib
S. Jagannathan et al.
LEUKEMIA (2015)
被撤回的出版物: Synthetic miR-145 mimic inhibits multiple myeloma cell growth in vitro and in vivo (Retracted article. See vol. 46, 2021)
Qi Zhang et al.
ONCOLOGY REPORTS (2015)
MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches
Marco Rossi et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
Lenka Kubiczkova et al.
HAEMATOLOGICA (2014)
Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation
Shuang Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Circulating miRNA markers show promise as new prognosticators for multiple myeloma
A. Rocci et al.
LEUKEMIA (2014)
Ectopic MicroRNA-150-5p Transcription Sensitizes Glucocorticoid Therapy Response in MM1S Multiple Myeloma Cells but Fails to Overcome Hormone Therapy Resistance in MM1R Cells
Ajay Palagani et al.
PLOS ONE (2014)
IL-17/miR-192/IL-17Rs Regulatory Feedback Loop Facilitates Multiple Myeloma Progression
Yuanyuan Sun et al.
PLOS ONE (2014)
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity
Lavinia Raimondi et al.
ONCOTARGET (2014)
MicroRNA: Important Player in the Pathobiology of Multiple Myeloma
Chonglei Bi et al.
BIOMED RESEARCH INTERNATIONAL (2014)
miR-202 expression concentration and its clinical significance in the serum of multiple myeloma patients
Jiajia Yu et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Circulating microRNAs in hematological diseases: principles, challenges, and perspectives
Sarah Grasedieck et al.
BLOOD (2013)
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
Nicola Amodio et al.
CELL CYCLE (2013)
Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
C. I. Jones et al.
BRITISH JOURNAL OF CANCER (2012)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
P. Tagliaferri et al.
CURRENT CANCER DRUG TARGETS (2012)
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma
Jing-jing Huang et al.
MEDICAL ONCOLOGY (2012)
Comparing the MicroRNA Spectrum between Serum and Plasma
Kai Wang et al.
PLOS ONE (2012)
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N. Amodio et al.
CELL DEATH & DISEASE (2012)
Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders
S. Yoshizawa et al.
BLOOD CANCER JOURNAL (2012)
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
S. K. Martin et al.
LEUKEMIA (2011)
Role of MicroRNAs From Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
Katherine R. Calvo et al.
SEMINARS IN HEMATOLOGY (2011)
MicroRNAs: New Players in Multiple Myeloma
Flavia Pichiorri et al.
Frontiers in Genetics (2011)
Multiple myeloma: biology of the disease
Anuj Mahindra et al.
BLOOD REVIEWS (2010)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
Aldo M. Roccaro et al.
BLOOD (2009)
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Deadenylation is a widespread effect of miRNA regulation
Ana Eulalio et al.
RNA (2009)
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi et al.
CANCER CELL (2008)
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Melissa Piper Hunter et al.
PLOS ONE (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Immunophenotypic studies of monoclonal gammopathy of undetermined significance
Horatiu Olteanu et al.
BMC CLINICAL PATHOLOGY (2008)
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
C. Welch et al.
ONCOGENE (2007)
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis
Fenghuang Zhan et al.
BLOOD (2007)
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
S. Vincent Rajkumar et al.
BLOOD REVIEWS (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Distinguishing primary and secondary translocations in multiple myeloma
Ana Gabrea et al.
DNA REPAIR (2006)
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies
B Barlogie et al.
BLOOD (2006)
Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party
BM Augustson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
R Yi et al.
GENES & DEVELOPMENT (2003)
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with total therapy I: interpretation in the context of global gene expression
J Shaughnessy et al.
BLOOD (2003)
Characterization of the MM.1 human multiple myeloma (MM) cell lines: A model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells
S Greenstein et al.
EXPERIMENTAL HEMATOLOGY (2003)
Endothelial cells in the bone marrow of patients with multiple myeloma
A Vacca et al.
BLOOD (2003)
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
H Avet-Loiseau et al.
BLOOD (2001)
Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance
H Gregersen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
